UB Paderborn / Katalog / Suche / in CDI

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.706-713

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase I, open-label dose-escalation trial of weekly (qw) BI 836880, a vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2)-blocking Nanobody, in patients (pts) with advanced/metastatic solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24013-e24013

2018

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours’ [Eur J Cancer 104 (November 2018) 1–8]

European journal of cancer (1990), 2019-09, Vol.119, p.198-198

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours

European journal of cancer (1990), 2018-11, Vol.104, p.1-8

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of afatinib plus standard-dose cetuximab in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2536-2536

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of volasertib (BI 6727) versus chemotherapy (CT) in platinum-resistant/refractory ovarian cancer (OC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5504-5504

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemoenzymatic synthesis of azacycloalkan-3-ols

Tetrahedron: asymmetry, 1999-08, Vol.10 (17), p.3449-3455

1999

Link zum Volltext

Verfügbarkeit prüfen

Chemoenzymatic synthesis of ( S)-2-cyanopiperidine, a key intermediate in the route to ( S)-pipecolic acid and 2-substituted piperidine alkaloids

Tetrahedron: asymmetry, 1998-05, Vol.9 (9), p.1597-1604

1998

Link zum Volltext

Verfügbarkeit prüfen

Glycosylation of acids under phase transfer conditions. Partial synthesis of saponins

Tetrahedron letters, 1994-08, Vol.35 (33), p.6107-6108

1994

Link zum Volltext

Verfügbarkeit prüfen

Structural Revision of Isoeudistomin U by Total Synthesis

Journal of natural products (Washington, D.C.), 1995-10, Vol.58 (10), p.1636-1639

1995

Link zum Volltext

Verfügbarkeit prüfen

Amygdalin as building block in oligosaccharide synthesis

Tetrahedron letters, 1993-08, Vol.34 (32), p.5083-5084

1993

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study

A phase I, open-label dose-escalation trial of weekly (qw) BI 836880, a vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2)-blocking Nanobody, in patients (pts) with advanced/metastatic solid tumors

Corrigendum to ‘A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours’ [Eur J Cancer 104 (November 2018) 1–8]

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours

Phase Ib study of afatinib plus standard-dose cetuximab in patients (pts) with advanced solid tumors

Phase II trial of volasertib (BI 6727) versus chemotherapy (CT) in platinum-resistant/refractory ovarian cancer (OC)

Chemoenzymatic synthesis of azacycloalkan-3-ols

Chemoenzymatic synthesis of ( S)-2-cyanopiperidine, a key intermediate in the route to ( S)-pipecolic acid and 2-substituted piperidine alkaloids

Glycosylation of acids under phase transfer conditions. Partial synthesis of saponins

Structural Revision of Isoeudistomin U by Total Synthesis

Amygdalin as building block in oligosaccharide synthesis

Suchergebnisse filtern